We are live on ! Find out more
NVO

Novo Nordisk

707 hedge funds and large institutions have $8.87B invested in Novo Nordisk in 2021 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 259 increasing their positions, 210 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 259 | Existing positions reduced: 210

21% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 56

1% more funds holding

Funds holding: 702707 (+5)

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

0.5% less ownership

Funds ownership: 15.06%14.56% (-0.5%)

7% less capital invested

Capital invested by funds: $9.54B → $8.87B (-$665M)

21% less call options, than puts

Call options by funds: $21.8M | Put options by funds: $27.5M

Holders
707
Holders Change
+5
Holders Change %
+0.71%
% of All Funds
12.41%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
68
Increased
259
Reduced
210
Closed
56
Calls
$21.8M
Puts
$27.5M
Net Calls
-$5.73M
Net Calls Change
-$19.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.68B -$142M -3,989,000 -7%
Fisher Asset Management
2
Fisher Asset Management
Washington
$1.08B +$16.1M +451,690 +1%
Bank of America
3
Bank of America
North Carolina
$505M -$4.59M -128,736 -0.9%
Loomis, Sayles & Company
4
Loomis, Sayles & Company
Massachusetts
$450M -$10.6M -298,562 -2%
Capital International Investors
5
Capital International Investors
California
$343M +$25.2M +707,566 +7%
Fayez Sarofim & Co
6
Fayez Sarofim & Co
Texas
$335M -$1.29M -36,184 -0.4%
F
7
Folketrygdfondet
Norway
$286M -$101M -2,829,584 -25%
State Street
8
State Street
Massachusetts
$275M -$10.7M -299,762 -4%
State Farm Mutual Automobile Insurance
9
State Farm Mutual Automobile Insurance
Illinois
$235M
BlackRock
10
BlackRock
New York
$223M +$132M +3,706,294 +128%
EHC
11
Everett Harris & Co
California
$220M +$2.7M +75,746 +1%
ClearBridge Investments
12
ClearBridge Investments
New York
$176M +$6.09M +170,866 +3%
PPA
13
Parametric Portfolio Associates
Washington
$143M +$7.86M +220,690 +5%
Northern Trust
14
Northern Trust
Illinois
$136M -$8.48M -238,074 -6%
Wells Fargo
15
Wells Fargo
California
$119M +$6.51M +182,910 +5%
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$106M +$6.29M +176,658 +6%
Envestnet Asset Management
17
Envestnet Asset Management
Illinois
$84.2M +$5.47M +153,532 +7%
SRIM
18
Saratoga Research & Investment Management
California
$82.4M +$3.9M +109,454 +5%
RJA
19
Raymond James & Associates
Florida
$75.2M +$5.33M +149,722 +7%
Goldman Sachs
20
Goldman Sachs
New York
$74.9M +$5.25M +147,422 +7%
SC
21
Saturna Capital
Washington
$72.6M +$353K +9,900 +0.5%
MG
22
Markel Group
Virginia
$72.5M
Natixis Advisors
23
Natixis Advisors
Massachusetts
$67M +$4.65M +130,660 +7%
Stifel Financial
24
Stifel Financial
Missouri
$63.1M +$9.53M +267,598 +17%
Ameriprise
25
Ameriprise
Minnesota
$62.7M +$805K +22,592 +1%

NVO Hedge Fund Activity: Q1 2021 in Review

707 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2021, worth a combined $8.87B — down 7% from $9.54B a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new NVO positions and 56 closed out — a net gain of 12 holders — while 259 added to existing stakes and 210 trimmed.

The largest buyer was BlackRock, adding an estimated $132M. The largest seller was Renaissance Technologies, cutting an estimated $142M.

  • 707 institutional investors held Novo Nordisk (NVO) as of Q1 2021, up from 702 in Q4 2020.
  • Funds reported $8.87B of Novo Nordisk stock for Q1 2021, down 7% quarter-over-quarter.
  • 68 funds opened new Novo Nordisk positions in Q1 2021 and 56 closed out, a net change of +12 holders.
  • The largest Novo Nordisk buyer in Q1 2021 was BlackRock, an estimated $132M added.
  • The largest Novo Nordisk seller in Q1 2021 was Renaissance Technologies, an estimated $142M sold.

Based on aggregated 13F filings for Q1 2021.